Clinical Trials Directory

Trials / Unknown

UnknownNCT01441609

Expression of Th9 Cells and Poor/Non-responsiveness to Hepatitis B Vaccination

Effect of the Expression Level of Th9 Cells and IL-9 In Poor/Non-responsiveness to Hepatitis B Vaccination

Status
Unknown
Phase
Study type
Observational
Enrollment
94 (estimated)
Sponsor
Beijing Municipal Science & Technology Commission · Academic / Other
Sex
All
Age
3 Years – 60 Years
Healthy volunteers
Accepted

Summary

An observational study will be performed in subjects aged 3-65 years old to describe the dynamic changes of cellular immunity after vaccination of hepatitis B vaccine, and to find out the expression levels of Th9 cells and IL9 in subjects with different response to the primary immunization (3 single -dose injunctions).

Detailed description

This study selected 74 volunteers which had the hepatitis B vaccine (immunization programs 0,1,6) , anti-HBs≤10mIU as the research subjects, and choose 20 volunteers which anti-HBs≥1000mIU as the control group, revaccination the groups according to the normal immunization programs, then the blood samples would be collected at 7th day, separate the PBMC and detect the expression levels of Th9 cells and IL9 by FCM, trying to find out the effects of Th9 and IL9 of non/poor -responsiveness subjects to hepatitis B.

Conditions

Timeline

Start date
2011-08-01
Primary completion
2012-04-01
Completion
2012-05-01
First posted
2011-09-27
Last updated
2011-09-28

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT01441609. Inclusion in this directory is not an endorsement.